Stay up-to-date with the latest Sciety news

Discover the latest updates on our company and investments in life science

Sciety news
Human neuron cell in a 3D Illustration.

Sciety and Karolinska Development invest SEK 67 million in PharmNovo


PRESS RELEASE. The Swedish pharmaceutical company PharmNovo, which is developing a new type of drug for nerve pain, has raised SEK 67 million in a new share issue led by Sciety. Karolinska Development AB participated in the share issue with SEK 20 million. The new capital will be used to…

Read more

Sciety invests SEK 34 million in Capitainer – an innovator of home-sampling solutions


PRESS RELEASE. Capitainer, a Swedish MedTech company supplying reliable solutions for self-sampling of blood and plasma, has raised a further SEK 34 million with Sciety and its investment syndicate in a new share issue. The company will use the proceeds to fund additional product validations, sales, and marketing to meet…

Read more
An elderly female listening to her doctor giving her some test results

Safer surgery saves lives – Swedish health-tech player takes the lead for improved quality of care


NEW COMPANY AT SCIETY. Long waiting time for surgery, deficiencies in patient safety, and high costs for care related to surgery. Healthcare faces significant challenges in Sweden and internationally while the demands for quality-improving measures are increasing. A Swedish health-tech player with an IT solution implementing structure and systematics in…

Read more
DNA strand and cancer cell in 3D

Sciety invests in cutting-edge biotech company NEOGAP Therapeutics


PRESS RELEASE. Sciety recently made an investment of over SEK 58 million in the cell therapy company NEOGAP Therapeutics, which is developing personalised immunotherapy for the treatment of cancer. The new capital will be used for a clinical phase I/II trial in colorectal cancer with an estimated start in 2022.…

Read more
Knee pain abstract design

Sciety invests in Synartro that develops novel therapy for osteoarthritis


PRESS RELEASE. The Swedish biotechnology company Synartro, which is developing a novel, improved treatment for knee osteoarthritis, has successfully raised SEK 34 million with Sciety and its investment syndicate. The new capital will be used for the company’s first clinical trial expected to start in 2022. ”We greatly appreciate the…

Read more

The Sciety syndicate and Segulah Medical Acceleration invest MSEK 106 in SAGA Diagnostics


PRESS RELEASE. The Swedish diagnostics company SAGA Diagnostics, which develops ultrasensitive liquid biopsy tests for early detection of cancer relapse and personalized cancer treatment, recently completed a share issue of SEK 106 million led by Segulah Medical Acceleration together with Sciety. Hadean Ventures, which invested in the company at an…

Read more
Man with knee pain is being examined by a physiotherapist.

Company that develops novel osteoarthritis treatment raises capital with Sciety


NEW COMPANY AT SCIETY. Osteoarthritis affects more than 320 million people globally and is a leading source of chronic pain and disability in Europe and the US. Only half of the patients receive adequate pain relief. Sciety is now financing a company whose drug candidate has the potential to provide…

Read more
Bild på lunga med tuberkulos och närbild på mycobacterium tuberculosis.

49 MSEK to EMPE Diagnostics with focus on rapid tuberculosis diagnostics


EMPE Diagnostics, which has developed a rapid test for the diagnosis and resistance determination of tuberculosis, the world’s deadliest infectious disease, has recently completed a share issue of SEK 23.5 million with Sciety. The company has also received a grant of SEK 25 million from EU Horizon 2020. The new…

Read more

The Sciety syndicate invests MSEK 31 in Capitainer


PRESS RELEASE. Capitainer, a Swedish Medtech company that supplies intelligent solutions for self-sampling of blood and plasma, recently completed a share issue of SEK 31 million with Sciety and its investment syndicate. The investors demonstrated strong interest, and the share issue was fully subscribed in two days. The new capital…

Read more

Company that develops innovative blood sampling raises capital with Sciety


NEW COMPANY AT SCIETY. Most blood sampling is still performed by qualified healthcare personnel at care facilities, but new technology that enables simple and reliable home sampling is now changing the landscape. Sciety finances a Swedish company that is at the forefront of the technology shift. Blood sampling has an…

Read more